Table 1 Demographic characteristics, psychotropic drug prescriptions (0–3 months after the diagnosis of dementia), and psychological symptoms for the whole sample and for the subpopulations
| Â | Overall sample | CD group | NH group | DIE group | DeR group |
|---|---|---|---|---|---|
Sample size, N (%) | 1278 | 391 (30.59) | 109 (8.53) | 479 (37.48) | 299 (23.40) |
Age at diagnose, Mean ± SD | 81.96 ± 7.13 | 79.04 ± 6.48 | 81.90 ± 6.19 | 84.19 ± 7.17 | 82.22 ± 6.86 |
Gender, Female, N (%) | 801 (62.68) | 234 (59.85) | 72 (66.06) | 287 (59.92) | 208 (69.57) |
Follow-up months, Median (IQR) | 38.92 (16.75–60.00) | 60 | 29.73 (14.77–46.41) | 25.36 (13.37–40.02) | 25.69 (10.32–41.69) |
Antipsychotics, N (%) | 70 (5.48) | 5 (1.28) | 7 (6.42) | 43 (8.98) | 15 (5.02) |
Anxiolytics, N (%) | 50 (3.91) | 16 (4.09) | 4 (3.67) | 17 (3.55) | 13 (4.35) |
Hypnotics and Sedatives, N (%) | 49 (3.83) | 17 (4.35) | 3 (2.75) | 25 (5.22) | 4 (1.34) |
Antidepressants, N (%) | 85 (6.65) | 30 (7.67) | 4 (3.67) | 28 (5.85) | 23 (7.69) |
Anti-dementia drugs, N (%) | 38 (2.97) | 13 (3.32) | 3 (2.75) | 12 (2.51) | 10 (3.34) |
Feeling anxious, N (%) | 74 (5.79) | 29 (7.42) | 3 (2.75) | 28 (5.85) | 14 (4.68) |
Feeling depressed, N (%) | 69 (5.40) | 29 (7.42) | 2 (1.83) | 25 (5.22) | 13 (4.35) |
Feeling angry, N (%) | 62 (4.85) | 20 (5.12) | 4 (3.67) | 22 (4.59) | 16 (5.35) |
Sleep disturbance, N (%) | 152 (11.89) | 66 (16.88) | 7 (6.42) | 54 (11.27) | 25 (8.36) |
Memory disturbance, N (%) | 483 (37.79) | 185 (47.31) | 38 (34.86) | 146 (30.48) | 114 (38.13) |
Delirium, N (%) | 103 (8.06) | 33 (8.44) | 5 (4.59) | 54 (11.27) | 11 (3.68) |
Anxiety disorder, N (%) | 53 (4.15) | 20 (5.12) | 4 (3.67) | 21 (4.38) | 8 (2.68) |
Depressive disorder, N (%) | 110 (8.61) | 49 (12.53) | 3 (2.75) | 36 (7.52) | 22 (7.36) |